Shanghai MicroPort Endovascular MedTech Co Ltd Sustainability Reports

The company engages in the research, development, manufacturing, and sale of aortic and peripheral vascular interventional medical devices. Its products include thoracic aortic stent graft systems, intraoperative stent systems, and peripheral artery or vein instruments.

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG00G6LFKZ2

4 reports from 2020 to 2023

• Shanghai MicroPort Endovascular MedTech Co Ltd 2023 Social Responsibility Report
• Shanghai MicroPort Endovascular MedTech Co Ltd 2022 Social Responsibility Report
• Shanghai MicroPort Endovascular MedTech Co Ltd 2021 Social Responsibility Report
• Shanghai MicroPort Endovascular MedTech Co Ltd 2020 Social Responsibility Report